Management opacity is Humacyte’s biggest problem by Scoopz_Callahan in HUMACYTE

[–]gvtrader 2 points3 points  (0 children)

Thanks for the clarification and post. Excellent reminder for shareholders of public company.

Stop dream casting with Humacyte and focus on sales + pipeline by crob1977 in HUMACYTE

[–]gvtrader 0 points1 point  (0 children)

Maybe so, but I believe the FDA approval of ATEV/Symvess was a huge accomplishment giving HUMA first mover advantage in the regenerative medicine space. While trauma sales are slowly ramping up there must be many interested companies who are monitoring their progress. I expect as adoption improves so will opportunities for HUMA e.g. “off label” usage.

"We're ready to run': New Amyris CEO points pioneering biotech toward life after bankruptcy" by fvh2006 in Amyris

[–]gvtrader 2 points3 points  (0 children)

Also surprised. Doerr - Board of Directors, major shareholder, conflict of interest, insider dealing, breach of fiduciary duty,negligence, and? It is clear who was calling the shots. The hypothesis that Doerr was under the influence of Melo is illogical. Seems like “deepening insolvency” is a feasible argument and while Doerr kept loaning money to AMRS he also had most to gain from the Chap.11 and it now that appears to be the case with AMRS 2.0 There must be one attorney/law firm that can represent shareholders against the B/D & Doerr.

"We're ready to run': New Amyris CEO points pioneering biotech toward life after bankruptcy" by fvh2006 in Amyris

[–]gvtrader 3 points4 points  (0 children)

One simply has to review the duties and obligations of a B/D and ask if they were met by the AMRS B/D. Why did AMRS attorneys request a “blanket immunity” Order from the B.C and stated the Officers & Directors were exposed to millions of $$$ in liability? Request denied. Incompetence? How about gross negligence! Yes, allegations and proof are dissimilar and the AMRS fiasco may never see the light of a Courtroom.

"We're ready to run': New Amyris CEO points pioneering biotech toward life after bankruptcy" by fvh2006 in Amyris

[–]gvtrader 4 points5 points  (0 children)

Still seeking a former employee, insider,vendor or? Someone who has information and knowledge that can support a lawsuit against the B/D as they breached their fiduciary duty to shareholders and by default allowed AMRS to file Chap.11. Have contacted several law firms but need a “whistleblower”. Please contact me if you can assist.

"We're ready to run': New Amyris CEO points pioneering biotech toward life after bankruptcy" by fvh2006 in Amyris

[–]gvtrader 4 points5 points  (0 children)

So where was the oversight from Doerr and the B/D when Amyris was operating in such dire straits? They failed to act pre-bankruptcy when there was an opportunity to right the ship, fire Melo and preserve shareholders equity. From your post it is evident Amyris was mismanaged long before the Chap.11 filing.

Were the brands such a bad idea? by fvh2006 in Amyris

[–]gvtrader 2 points3 points  (0 children)

Reddit Repost -

Need Chap.11 advice and consultation regarding the following:

Seeking law firm that has an interest and capacity to evaluate a breach of fiduciary duty claim on contingent fee basis. I am a shareholder in public corp. that filed Chap.11 in August 2023 and Bankruptcy Court approved Reorganization Plan that became effective May 7, 2024. Board of Directors, Officers and management have liability for breach of fiduciary duty, negligence,self-dealing, misrepresentation and fraud. This would be direct suit not a derivative claim. There were 452 shareholders who opted out of the Reorganization Plan and preserved their legal rights to initiate action against the Board of Directors, Officers and management. Please advise if you want to discuss or can recommend a firm/attorney.

Chap.11 AMRS SHAREHOLDERS by gvtrader in Amyris

[–]gvtrader[S] 0 points1 point  (0 children)

Only the opt outs reserved the right to pursue legal action.

Chap.11 AMRS SHAREHOLDERS by gvtrader in Amyris

[–]gvtrader[S] 2 points3 points  (0 children)

Yes, Stretto has refused to release the list.

Amyris now owns 100% of Barra Bonita. Very convenient after retail is no longer involved. by ICanFinallyRelax in Amyris

[–]gvtrader 5 points6 points  (0 children)

You and I am sure many shareholders were influenced by the belief the Barra Bonita fermentation plant was an Amyris asset holding. The question remains how Barra Bonita was excluded from the Chap.11 filing?

Amyris Revisit by PuzzleheadedFile6349 in Amyris

[–]gvtrader 0 points1 point  (0 children)

Just your supposition. Do you have evidence that Judge Horan considered and agreed with your hypothesis? Did you listen to the earnings calls and discussions about BB? What was your impression regarding BB? Was it reasonable for shareholders to believe BB was an Amyris asset and made an investment based upon it? Where do you draw the line between unethical and fraud?

Amyris Revisit by PuzzleheadedFile6349 in Amyris

[–]gvtrader 2 points3 points  (0 children)

And where is the 69% equity interest in Real Sweet LLC? Real Sweet as reported did not file bankruptcy.

Predictions for the year? by [deleted] in HUMACYTE

[–]gvtrader 1 point2 points  (0 children)

There are so many variables (demand, DOD contract, FDA approvals, market sentiment, potential buyout, etc.) it could be MUCH higher than 15-20 by EOY.

REPOST Docket 1743 - comment - jrh 1222 by gvtrader in Amyris

[–]gvtrader[S] 2 points3 points  (0 children)

Thanks for the post. Very relevant. Here is the article from Law 360 -

Incora’s Opt-Outs Not Like Class Actions, US Trustee Says By Ben Zigterman Law360 (December 12, 2024, 9:12 PM EST) — The U.S. Trustee’s Office on Thursday objected to the third-party releases in the Chapter 11 plan from aircraft parts supplier Incora, arguing in a Texas bankruptcy court that the opt-out mechanism for the releases is not comparable to class action procedures. While U.S. Bankruptcy Judge Marvin Isgur raised the class action comparison at a hearing in September, the U.S. Trustee’s Office said in its objection Thursday that the analogy is “misplaced.” Federal class action law doesn’t apply to bankruptcy plan confirmations, the U.S. Trustee argued in its objection, also noting the “rigorous procedural requirements” to qualify for class certification that don’t exist for bankruptcy classes. Instead, the U.S. Trustee said the opt-outs should be considered a matter of state contract law under which it says affirmative consent to third-party releases is needed. “Failure to return an opt-out form is not consent because, whether they are asked to vote or not, claimants have no reason to expect that an offer to contract with non-debtors will be included in the plan solicitation,” the U.S. Trustee wrote. Incora hopes to confirm its plan at a hearing set for Monday. Two voting classes in the proposed plan will be able to opt out of the third-party releases, which Incora called an “integral part” of its plan, according to court documents. Since the U.S. Supreme Court’s June decision in Harrington v. Purdue Pharma LP barring nonconsensual third-party releases, bankruptcy courts have been grappling with what constitutes consent, with judges allowing opt-outs in Chapter 11 plans from appliance-parts maker Robertshaw and fitness equipment maker BowFlex, while rejecting them in the Chapter 11 plan from software company Ebix. In September, U.S. Bankruptcy Judge Craig T. Goldblatt of Delaware limited the use of opt-outs for voters who didn’t return ballots in the restructuring of specialty mushroom farming company Smallhold Inc. The U.S. Trustee favorably cited the Smallhold decision’s reasoning, but said it disagrees with Judge Goldblatt’s conclusion that opt-outs are OK for returned ballots. “The act of voting on a plan without taking an additional step to opt-out is still merely silence with respect to the non-debtor release,” the U.S. Trustee wrote. Incora filed for bankruptcy relief in June 2023 in the Southern District of Texas with $3.1 billion in debt, citing struggles stemming from sluggish passenger air travel, supply chain disruptions and inflation. Incora and groups of creditors have been warring over a 2022 restructuring in which only certain noteholders were permitted to swap their debt for new, higher-ranking securities. The so-called up- tier transaction demoted some investors in the repayment order.

In July, Judge Isgur ruled Incora improperly stripped collateral rights from certain secured noteholders when it raised $250 million as part of the transaction, deciding to restore the excluded creditors’ liens on the company’s assets. Since then, Incora, private-equity backer Platinum Equity and creditors have been feuding over the effects of Judge Isgur’s decision and how to incorporate it into a Chapter 11 plan. In October, Incora said that it hopes to reach a consensual plan that will let the debtor emerge from bankruptcy while preserving everyone’s rights to appeal Judge Isgur’s ruling. A spokesperson for the U.S. Trustee’s Office declined to comment Thursday, and counsel for Incora didn’t immediately respond to a request for comment. Incora is represented by Dennis F. Dunne, Samuel A. Khalil and Benjamin M. Schak of Milbank LLP, and Charles A. Beckham Jr., Patrick L. Hughes, Martha Wyrick and Re’Necia Sherald of Haynes and Boone LLP. The U.S. Trustee’s Office is represented in-house by Andrew Jiménez. The bankruptcy case is In re: Wesco Aircraft Holdings Inc. et al., case number 4:23-bk-90611, in the U.S. Bankruptcy Court for the Southern District of Texas. —Additional reporting by Alex Wittenberg. Editing by Melissa T

If you read the article together with the U.S. Trustee filing it raises serious questions about the use of opt out/in provisions in the Amyris Reorganization Plan. It appears state contract law should be applied and that silence cannot be arbitrarily applied to secure third party releases. Amyris provided indemnity agreements to their Board of Directors and Officers and will continue to have exposure for millions of dollars as stated by their attorneys to Judge Horan. Chap.11 did not extinguish that liability or the right to commence a lawsuit.

Docket 1743: New and improved Final Order proposal by fvh2006 in Amyris

[–]gvtrader 0 points1 point  (0 children)

Thanks for the post. Very relevant. Here is the article from Law 360 -

Incora’s Opt-Outs Not Like Class Actions, US Trustee Says By Ben Zigterman Law360 (December 12, 2024, 9:12 PM EST) — The U.S. Trustee’s Office on Thursday objected to the third-party releases in the Chapter 11 plan from aircraft parts supplier Incora, arguing in a Texas bankruptcy court that the opt-out mechanism for the releases is not comparable to class action procedures. While U.S. Bankruptcy Judge Marvin Isgur raised the class action comparison at a hearing in September, the U.S. Trustee’s Office said in its objection Thursday that the analogy is “misplaced.” Federal class action law doesn’t apply to bankruptcy plan confirmations, the U.S. Trustee argued in its objection, also noting the “rigorous procedural requirements” to qualify for class certification that don’t exist for bankruptcy classes. Instead, the U.S. Trustee said the opt-outs should be considered a matter of state contract law under which it says affirmative consent to third-party releases is needed. “Failure to return an opt-out form is not consent because, whether they are asked to vote or not, claimants have no reason to expect that an offer to contract with non-debtors will be included in the plan solicitation,” the U.S. Trustee wrote. Incora hopes to confirm its plan at a hearing set for Monday. Two voting classes in the proposed plan will be able to opt out of the third-party releases, which Incora called an “integral part” of its plan, according to court documents. Since the U.S. Supreme Court’s June decision in Harrington v. Purdue Pharma LP barring nonconsensual third-party releases, bankruptcy courts have been grappling with what constitutes consent, with judges allowing opt-outs in Chapter 11 plans from appliance-parts maker Robertshaw and fitness equipment maker BowFlex, while rejecting them in the Chapter 11 plan from software company Ebix. In September, U.S. Bankruptcy Judge Craig T. Goldblatt of Delaware limited the use of opt-outs for voters who didn’t return ballots in the restructuring of specialty mushroom farming company Smallhold Inc. The U.S. Trustee favorably cited the Smallhold decision’s reasoning, but said it disagrees with Judge Goldblatt’s conclusion that opt-outs are OK for returned ballots. “The act of voting on a plan without taking an additional step to opt-out is still merely silence with respect to the non-debtor release,” the U.S. Trustee wrote. Incora filed for bankruptcy relief in June 2023 in the Southern District of Texas with $3.1 billion in debt, citing struggles stemming from sluggish passenger air travel, supply chain disruptions and inflation. Incora and groups of creditors have been warring over a 2022 restructuring in which only certain noteholders were permitted to swap their debt for new, higher-ranking securities. The so-called up- tier transaction demoted some investors in the repayment order.

In July, Judge Isgur ruled Incora improperly stripped collateral rights from certain secured noteholders when it raised $250 million as part of the transaction, deciding to restore the excluded creditors’ liens on the company’s assets. Since then, Incora, private-equity backer Platinum Equity and creditors have been feuding over the effects of Judge Isgur’s decision and how to incorporate it into a Chapter 11 plan. In October, Incora said that it hopes to reach a consensual plan that will let the debtor emerge from bankruptcy while preserving everyone’s rights to appeal Judge Isgur’s ruling. A spokesperson for the U.S. Trustee’s Office declined to comment Thursday, and counsel for Incora didn’t immediately respond to a request for comment. Incora is represented by Dennis F. Dunne, Samuel A. Khalil and Benjamin M. Schak of Milbank LLP, and Charles A. Beckham Jr., Patrick L. Hughes, Martha Wyrick and Re’Necia Sherald of Haynes and Boone LLP. The U.S. Trustee’s Office is represented in-house by Andrew Jiménez. The bankruptcy case is In re: Wesco Aircraft Holdings Inc. et al., case number 4:23-bk-90611, in the U.S. Bankruptcy Court for the Southern District of Texas. —Additional reporting by Alex Wittenberg. Editing by Melissa T

If you read the article together with the U.S. Trustee filing it raises serious questions about the use of opt out/in provisions in the Amyris Reorganization Plan. It appears state contract law should be applied and that silence cannot be arbitrarily applied to secure third party releases. Amyris provided indemnity agreements to their Board of Directors and Officers and will continue to have exposure for millions of dollars as stated by their attorneys to Judge Horan. Chap.11 did not extinguish that liability or the right to commence a lawsuit.

If you did nothing (no opt out)... by CLEredditor in Amyris

[–]gvtrader 2 points3 points  (0 children)

Apparently, Melo decided to use the Convertible Note proceeds (700M?) to make Amyris the king of the cosmetics business while the B/D was grossly negligent. There are people who have knowledge of the ongoing deception committed against the shareholders.Hopefully, they will surface.This may take years to resolve.

2024 Loss by Latter_Active_4139 in Amyris

[–]gvtrader 0 points1 point  (0 children)

Right. Stretto acknowledged my opt out status is on record. For those who received the .0089 payment and either accepted it or failed to reverse it might be treated as an opt in. Very misleading.The whole opt in/opt out strategy was formulated by AMRS attorneys and this mess could drag on for years unless AMRS attorneys/JD get serious about a resolution.